Seeking Alpha

Prana Biotechnology (PRAN +3.2%) moves up after being initiated at Burrill Institutional...

Prana Biotechnology (PRAN +3.2%) moves up after being initiated at Burrill Institutional Research with an Outperform and a price target of $5 a share. Burrill cites the company's progress in developing technology for the treatment of neurodegenerative disorders. Yesterday PRAN announced that it's completed recruitment in its Phase IIa clinical trial using its experimental drug PBT2 for the treatment of patients with Huntington Disease.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|